The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

E.A. Pyadushkina

National Center for Health Technology Assessment

V.I. Ignatieva

National Medical Research Center for Therapy and Preventive Medicine;
I.M. Sechenov First Moscow State Medical University (Sechenov University);
Russian Medical Academy of Continuing Professional Education

E.E. Yagnenkova

National Center for Health Technology Assessment

E.V. Derkach

National Center for Health Technology Assessment

Electronic reprint

Cost-effectiveness analysis of anifrolumab therapy in patients with systemic lupus erythematosus in the Russian Federation

Authors:

E.A. Pyadushkina, V.I. Ignatieva, E.E. Yagnenkova, E.V. Derkach

More about the authors

Downloaded: 2

Expires: 01.27.2025

To cite this article:

Pyadushkina EA, Ignatieva VI, Yagnenkova EE, Derkach EV. Cost-effectiveness analysis of anifrolumab therapy in patients with systemic lupus erythematosus in the Russian Federation. Medical Technologies. Assessment and Choice. 2023;(4):33‑41. (In Russ.)
https://doi.org/10.17116/medtech20234504133

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.